Participants in the type 2 diabetes group compared with the control group had 59% higher plasma concentrations of FVIIa-AT (median [IQR] 89 [79–112] vs 56 [48–71] pmol/l, p < 0.0001) but not TF (median [IQR] 1.38 [1.26–1.53] vs 1.29 [1.17–1.44] pmol/l, p = 0.07) or F1+2 (median [IQR] 196 [146–238] vs 182 [172–192] pmol/l, p = 0.42). The gene discussed is TF; the disease is type 2 diabetes mellitus.